Authors
Loading...
Review highlights the potential of genetically modified natural killer cells to enhance immunotherapy efficacy and safety.
Burón et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: